Literature DB >> 2462500

xid mice fail to express an anti-dextran immune response but carry alpha(1-3)dextran-specific lymphocytes in their potential repertoire.

H C Selinka1, R Bösing-Schneider.   

Abstract

Even after repeated immunizations with alpha(1-3)dextran (Dex) male (CBA/N x BALB/c)F1 mice fail to produce specific antibodies whereas nondefective female littermates express an idiotype-positive anti-Dex immune response. This failure of xid mice to express serum anti-Dex immunoglobulins is not only limited to immunization with the thymus-independent (TI-2) antigen Dex, since immunization with anti-idiotypic antibodies against Dex-specific idiotypes does not overcome this defect. When xid lymphocytes are cultured in the presence of mitogens, in vitro anti-Dex responses are markedly reduced. We show here that alpha(1-3)Dex-specific hybridomas can be established by fusion of splenic lymphocytes from xid mice to Sp2/0 myeloma cells. Therefore, these mice do carry the potential to generate B cells specific for Dex. All hybridoma antibodies were found to be of IgM isotype, bearing the lambda light chain typical for alpha(1-3)Dex-specific antibodies. Whereas monoclonal anti-Dex antibodies obtained from spleen cell hybridomas from female littermates showed variable idiotope patterns, hybridoma proteins from the immune-defective NBF1-xid mouse expressed only a limited pattern of Dex-specific idiotopes, suggesting that these hybridomas derived from a common precursor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462500     DOI: 10.1002/eji.1830181111

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  VH gene family expression in mice with the xid defect.

Authors:  S H Feng; K E Stein
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

2.  Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children.

Authors:  Nicola Cotugno; Veronica Santilli; Giuseppe Rubens Pascucci; Emma Concetta Manno; Lesley De Armas; Suresh Pallikkuth; Annalisa Deodati; Donato Amodio; Paola Zangari; Sonia Zicari; Alessandra Ruggiero; Martina Fortin; Christina Bromley; Rajendra Pahwa; Paolo Rossi; Savita Pahwa; Paolo Palma
Journal:  Front Immunol       Date:  2020-10-05       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.